# CDKL5

## Overview
The CDKL5 gene encodes the cyclin-dependent kinase-like 5 protein, a serine/threonine kinase that plays a pivotal role in neuronal development and function. This protein is involved in various cellular processes, including the regulation of dendritic spine morphology, synaptic signaling, and neuronal morphogenesis, through its interactions with key proteins such as NGL-1, PSD95, Rac1, MeCP2, and DNMT1 (Chen2010CDKL5; Ricciardi2012CDKL5; KilstrupNielsen2012What). CDKL5's dual localization in the cytoplasm and nucleus allows it to influence both cytoskeletal dynamics and gene expression, underscoring its importance in complex neuronal signaling pathways (KilstrupNielsen2012What). Mutations in the CDKL5 gene are linked to CDKL5 Deficiency Disorder (CDD), a severe neurological condition characterized by early-onset epileptic encephalopathy and developmental delays, highlighting the clinical significance of this gene in human health (Leonard2022CDKL5; Siri2021CDKL5).

## Structure
The CDKL5 protein is a serine/threonine kinase characterized by a distinct molecular structure. Its primary structure includes an N-terminal catalytic domain spanning amino acids 13-297, which is homologous to other members of the CDKL family (KilstrupNielsen2012What). This domain contains an ATP-binding site and a serine/threonine protein kinase active site, essential for its enzymatic activity (Mari2005CDKL5). The protein also features a Thr-Xaa-Tyr (TEY) motif at amino acids 169-171, involved in dual phosphorylation, a common activation mechanism in MAP kinases (KilstrupNielsen2012What).

CDKL5 has a unique long C-terminal tail of over 600 amino acids, which is highly conserved among different orthologs (KilstrupNielsen2012What). This region includes nuclear import (NLS) and export (NES) signals, influencing its subcellular localization (KilstrupNielsen2012What). The protein is capable of autophosphorylation, and while a consensus sequence for its kinase activity has not been established, it may function as a proline-directed kinase due to a critical arginine residue in its kinase subdomain VIII (KilstrupNielsen2012What).

CDKL5 exists in multiple splice variant isoforms, with the primary isoform, CDKL5 115, being 1030 amino acids long and mainly expressed in the testis. Other isoforms, such as CDKL5 107, are relevant for brain function and have altered C-terminal regions (KilstrupNielsen2012What).

## Function
The CDKL5 gene encodes a serine/threonine kinase that plays a crucial role in neuronal development and function. In healthy human cells, CDKL5 is involved in maintaining the structure and function of dendritic spines, which are essential for synaptic connections and neuronal communication. It achieves this by phosphorylating NGL-1, facilitating its interaction with PSD95, a protein critical for synaptic signaling and plasticity (Ricciardi2012CDKL5). This interaction is vital for the formation and maintenance of dendritic spines, impacting learning and memory processes (Ricciardi2012CDKL5).

CDKL5 is also involved in regulating the actin cytoskeleton and dendritic arborization through its interaction with Rac1, a regulator of actin dynamics (Chen2010CDKL5). This interaction is crucial for neuronal morphogenesis, as CDKL5 forms a protein complex with Rac1, which is necessary for proper dendrite development (Chen2010CDKL5).

In addition to its role in the cytoplasm, CDKL5 functions in the nucleus, where it interacts with proteins like MeCP2 and DNMT1, influencing gene expression and DNA methylation (KilstrupNielsen2012What). This dual localization underscores its involvement in complex signaling pathways that affect neuronal functions and development (KilstrupNielsen2012What).

## Clinical Significance
Mutations in the CDKL5 gene are associated with CDKL5 Deficiency Disorder (CDD), a severe neurological condition characterized by early-onset epileptic encephalopathy, developmental delays, and intellectual disabilities. This disorder is more prevalent in females, with a female to male ratio of 4:1, and is marked by early-onset refractory epilepsy and severe developmental delay (Siri2021CDKL5). The clinical presentation of CDD can vary widely, influenced by factors such as the type and position of CDKL5 variants, with truncating variants often leading to more severe phenotypes (Leonard2022CDKL5).

CDKL5 mutations are also linked to conditions resembling Rett syndrome, particularly in females with early-onset seizures and severe intellectual disability (Bahi‐Buisson2012Recurrent). These mutations can result in a range of seizure types, including infantile spasms, myoclonic, and generalized tonic-clonic seizures (KilstrupNielsen2012What). In males, CDKL5 mutations often lead to a more severe phenotype, with higher frequencies of infantile spasms and brain atrophy (Liang2019Phenotypic).

The disorder is characterized by significant clinical variability, with symptoms such as hypotonia, microcephaly, and impaired communication skills (Kluckova2021Clinical). Despite the identification of over 300 disease-causing CDKL5 variants, establishing clear genotype-phenotype correlations remains challenging (Siri2021CDKL5).

## Interactions
CDKL5 interacts with several proteins, playing a crucial role in neuronal development and function. It binds to and phosphorylates MeCP2, a protein associated with Rett syndrome, influencing dendritic and synaptic development (BahiBuisson2011&lt; KilstrupNielsen2012What; CDKL5&lt; i&gt; Related). CDKL5 also phosphorylates DNMT1, a process that is DNA-dependent and suggests a role in DNA methylation (Zhu2018Molecular; BahiBuisson2011&lt; CDKL5&lt; i&gt; Related).

In the cytoplasm, CDKL5 interacts with Rac1, a protein involved in actin cytoskeleton regulation, which is essential for dendritic spine morphology and neuronal morphogenesis (Chen2010CDKL5; KilstrupNielsen2012What). CDKL5 also binds to PSD-95, a scaffolding protein, in a palmitoylation-dependent manner, which is critical for synaptic targeting and dendritic spine development (Zhu2013Palmitoylationdependent).

CDKL5 phosphorylates NGL-1, enhancing its interaction with PSD-95, which is important for synapse development (Zhu2018Molecular). It also interacts with SMAD3, a mediator of TGF-β signaling, specifically phosphorylating its MH1 domain (Fuchs2019CDKL5). These interactions highlight CDKL5's involvement in various signaling pathways crucial for neuronal function.


## References


[1. (Zhu2018Molecular) Yong‐Chuan Zhu and Zhi‐Qi Xiong. Molecular and synaptic bases of cdkl5 disorder. Developmental Neurobiology, 79(1):8–19, October 2018. URL: http://dx.doi.org/10.1002/dneu.22639, doi:10.1002/dneu.22639. This article has 67 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/dneu.22639)

[2. (Chen2010CDKL5) Qian Chen, Yong-Chuan Zhu, Jing Yu, Sheng Miao, Jing Zheng, Li Xu, Yang Zhou, Dan Li, Chi Zhang, Jiong Tao, and Zhi-Qi Xiong. Cdkl5, a protein associated with rett syndrome, regulates neuronal morphogenesis via rac1 signaling. The Journal of Neuroscience, 30(38):12777–12786, September 2010. URL: http://dx.doi.org/10.1523/jneurosci.1102-10.2010, doi:10.1523/jneurosci.1102-10.2010. This article has 145 citations.](https://doi.org/10.1523/jneurosci.1102-10.2010)

[3. (Leonard2022CDKL5) Helen Leonard, Jenny Downs, Tim A Benke, Lindsay Swanson, Heather Olson, and Scott Demarest. Cdkl5 deficiency disorder: clinical features, diagnosis, and management. The Lancet Neurology, 21(6):563–576, June 2022. URL: http://dx.doi.org/10.1016/s1474-4422(22)00035-7, doi:10.1016/s1474-4422(22)00035-7. This article has 65 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/s1474-4422(22)00035-7)

[4. (Fuchs2019CDKL5) Claudia Fuchs, Giorgio Medici, Stefania Trazzi, Laura Gennaccaro, Giuseppe Galvani, Chiara Berteotti, Elisa Ren, Manuela Loi, and Elisabetta Ciani. Cdkl5 deficiency predisposes neurons to cell death through the deregulation of smad3 signaling. Brain Pathology, 29(5):658–674, March 2019. URL: http://dx.doi.org/10.1111/bpa.12716, doi:10.1111/bpa.12716. This article has 25 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/bpa.12716)

[5. (Siri2021CDKL5) Barbara Siri, Costanza Varesio, Elena Freri, Francesca Darra, Simone Gana, Davide Mei, Francesco Porta, Elena Fontana, Giulia Galati, Roberta Solazzi, Marcello Niceta, Pierangelo Veggiotti, and Enrico Alfei. Cdkl5 deficiency disorder in males: five new variants and review of the literature. European Journal of Paediatric Neurology, 33:9–20, July 2021. URL: http://dx.doi.org/10.1016/j.ejpn.2021.04.007, doi:10.1016/j.ejpn.2021.04.007. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ejpn.2021.04.007)

[6. (Bahi‐Buisson2012Recurrent) Nadia Bahi‐Buisson, Nathalie Villeneuve, Emilie Caietta, Aurélia Jacquette, Helene Maurey, Gert Matthijs, Hilde Van Esch, Andrée Delahaye, Anne Moncla, Mathieu Milh, Flore Zufferey, Bertrand Diebold, and Thierry Bienvenu. Recurrent mutations in the cdkl5 gene: genotype–phenotype relationships. American Journal of Medical Genetics Part A, 158A(7):1612–1619, June 2012. URL: http://dx.doi.org/10.1002/ajmg.a.35401, doi:10.1002/ajmg.a.35401. This article has 51 citations.](https://doi.org/10.1002/ajmg.a.35401)

[7. (Mari2005CDKL5) Francesca Mari, Sara Azimonti, Ilaria Bertani, Fabrizio Bolognese, Elena Colombo, Rossella Caselli, Elisa Scala, Ilaria Longo, Salvatore Grosso, Chiara Pescucci, Francesca Ariani, Giuseppe Hayek, Paolo Balestri, Anna Bergo, Gianfranco Badaracco, Michele Zappella, Vania Broccoli, Alessandra Renieri, Charlotte Kilstrup-Nielsen, and Nicoletta Landsberger. Cdkl5 belongs to the same molecular pathway of mecp2 and it is responsible for the early-onset seizure variant of rett syndrome. Human Molecular Genetics, 14(14):1935–1946, May 2005. URL: http://dx.doi.org/10.1093/hmg/ddi198, doi:10.1093/hmg/ddi198. This article has 254 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddi198)

[8. (Zhu2013Palmitoylationdependent) Yong-Chuan Zhu, Dan Li, Lu Wang, Bin Lu, Jing Zheng, Shi-Lin Zhao, Rong Zeng, and Zhi-Qi Xiong. Palmitoylation-dependent cdkl5–psd-95 interaction regulates synaptic targeting of cdkl5 and dendritic spine development. Proceedings of the National Academy of Sciences, 110(22):9118–9123, May 2013. URL: http://dx.doi.org/10.1073/pnas.1300003110, doi:10.1073/pnas.1300003110. This article has 88 citations.](https://doi.org/10.1073/pnas.1300003110)

[9. (Kluckova2021Clinical) Daniela Kluckova, Miriam Kolnikova, Veronika Medova, Csaba Bognar, Tomas Foltan, Lucia Svecova, Andrej Gnip, Ludevit Kadasi, Andrea Soltysova, and Andrej Ficek. Clinical manifestation of cdkl5 deficiency disorder and identified mutations in a cohort of slovak patients. Epilepsy Research, 176:106699, October 2021. URL: http://dx.doi.org/10.1016/j.eplepsyres.2021.106699, doi:10.1016/j.eplepsyres.2021.106699. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.eplepsyres.2021.106699)

[10. (KilstrupNielsen2012What) Charlotte Kilstrup-Nielsen, Laura Rusconi, Paolo La Montanara, Dalila Ciceri, Anna Bergo, Francesco Bedogni, and Nicoletta Landsberger. What we know and would like to know about cdkl5 and its involvement in epileptic encephalopathy. Neural Plasticity, 2012:1–11, 2012. URL: http://dx.doi.org/10.1155/2012/728267, doi:10.1155/2012/728267. This article has 77 citations and is from a peer-reviewed journal.](https://doi.org/10.1155/2012/728267)

[11. (Liang2019Phenotypic) Jao-Shwann Liang, Hsin Huang, Jinn-Shyan Wang, and Jyh-Feng Lu. Phenotypic manifestations between male and female children with cdkl5 mutations. Brain and Development, 41(9):783–789, October 2019. URL: http://dx.doi.org/10.1016/j.braindev.2019.05.003, doi:10.1016/j.braindev.2019.05.003. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.braindev.2019.05.003)

[12. (Ricciardi2012CDKL5) Sara Ricciardi, Federica Ungaro, Melanie Hambrock, Nils Rademacher, Gilda Stefanelli, Dario Brambilla, Alessandro Sessa, Cinzia Magagnotti, Angela Bachi, Elisa Giarda, Chiara Verpelli, Charlotte Kilstrup-Nielsen, Carlo Sala, Vera M. Kalscheuer, and Vania Broccoli. Cdkl5 ensures excitatory synapse stability by reinforcing ngl-1–psd95 interaction in the postsynaptic compartment and is impaired in patient ipsc-derived neurons. Nature Cell Biology, 14(9):911–923, August 2012. URL: http://dx.doi.org/10.1038/ncb2566, doi:10.1038/ncb2566. This article has 216 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncb2566)